Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis

NCT06644638 · clinicaltrials.gov ↗
COMPLETED
Status
3632
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Novartis